Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 18.94%286.19M | -29.16%1.02B | -34.39%726.55M | -38.68%462.29M | -38.42%240.61M | -16.02%1.44B | -7.04%1.11B | 8.17%753.94M | 29.70%390.74M | -3.47%1.71B |
Operating revenue | 18.94%286.19M | -29.16%1.02B | -34.39%726.55M | -38.68%462.29M | -38.42%240.61M | -16.02%1.44B | -7.04%1.11B | 8.17%753.94M | 29.70%390.74M | -3.47%1.71B |
Other operating revenue | ---- | 77.07%1.76M | ---- | -91.49%893.91K | ---- | -96.26%991.17K | ---- | 183.72%10.5M | ---- | 205.72%26.49M |
Total operating cost | 18.66%288.91M | -25.17%1.04B | -31.27%740.5M | -36.15%466.09M | -34.74%243.48M | -14.66%1.4B | -5.88%1.08B | 7.77%729.97M | 24.67%373.09M | -2.64%1.63B |
Operating cost | 19.88%246.18M | -28.85%876.2M | -34.44%624.57M | -39.61%392.2M | -38.80%205.35M | -17.28%1.23B | -8.49%952.63M | 6.83%649.45M | 28.06%335.56M | -0.29%1.49B |
Operating tax surcharges | 38.84%703.28K | 20.94%2.86M | 15.93%1.95M | 1.63%1.12M | -16.27%506.52K | -5.27%2.36M | -8.44%1.69M | -6.68%1.1M | 21.56%604.96K | 32.66%2.5M |
Operating expense | -3.32%19M | -3.92%81.75M | -7.39%60.27M | -8.23%38.65M | 3.16%19.65M | 17.97%85.08M | 25.43%65.08M | 22.40%42.12M | 6.73%19.05M | -31.26%72.12M |
Administration expense | 21.40%15.37M | 16.36%64.71M | -0.50%40.46M | 1.86%25.24M | 17.14%12.66M | 19.42%55.62M | 18.13%40.66M | 4.45%24.78M | -14.90%10.81M | -11.58%46.57M |
Financial expense | 171.17%821.76K | 101.96%118.9K | 48.62%-2.3M | 24.70%-1.97M | -93.93%-1.15M | -278.65%-6.05M | -320.23%-4.47M | -282.18%-2.62M | -53.62%-595.4K | 43.59%-1.6M |
-Interest expense (Financial expense) | --1.61M | 2,544.46%3.3M | 129.06%365.08K | -18.48%95.58K | --0 | -60.16%124.78K | -20.29%159.38K | 35.25%117.25K | 712.07%113.43K | -9.07%313.21K |
-Interest Income (Financial expense) | 31.08%-802.44K | 47.98%-3.24M | 41.88%-2.7M | 24.47%-2.1M | -61.33%-1.16M | -208.10%-6.23M | -240.74%-4.64M | -228.04%-2.78M | -67.49%-721.7K | 39.38%-2.02M |
Research and development | 5.87%6.84M | -31.41%18.22M | -28.84%15.55M | -28.34%10.86M | -15.70%6.46M | 0.01%26.57M | 30.95%21.85M | 39.96%15.15M | 16.64%7.66M | -9.60%26.57M |
Credit Impairment Loss | -165.08%-3.82M | -114.18%-3.99M | -61.40%-2.93M | -0.13%-2.07M | 15.90%-1.44M | -186.99%-1.86M | 25.11%-1.82M | 18.29%-2.07M | -72.47%-1.71M | -264.40%-649.74K |
Asset Impairment Loss | ---73.48K | -2,701.68%-5.12M | -31.50%56.27K | -13.11%71.37K | --0 | -115.40%-182.8K | 487.68%82.14K | 487.68%82.14K | ---- | 68.38%-84.87K |
Other net revenue | -206.86%-3.3M | -139.08%-6.02M | -104.85%-425.52K | -90.40%371.22K | -127.22%-1.07M | 19.01%15.39M | -14.10%8.77M | 541.07%3.87M | 4,021.10%3.95M | 3.88%12.94M |
Asset deal income | 196.61%11.65K | -100.02%-663.88 | -68.17%2.92K | -57.13%3.93K | -57.13%3.93K | 7,488.95%4.39M | 452.82%9.16K | 523.51%9.16K | --9.16K | 12.25%-59.44K |
Other revenue | 60.91%581.64K | -76.25%3.1M | -76.69%2.45M | -59.51%2.37M | -93.60%361.47K | -4.95%13.05M | -17.09%10.5M | 248.50%5.84M | 533.51%5.65M | 10.78%13.73M |
Operating profit | -52.65%-6.02M | -158.91%-32.92M | -137.15%-14.38M | -112.29%-3.42M | -118.26%-3.94M | -36.14%55.89M | -31.69%38.69M | 48.46%27.84M | 1,039.34%21.6M | -16.08%87.53M |
Add:Non operating Income | -19.20%7.5K | -70.76%146.45K | -78.95%99.46K | -96.74%14.2K | -97.48%9.28K | -6.85%500.82K | 410.19%472.49K | 500.09%436.03K | 801.57%368.68K | 227.35%537.63K |
Less:Non operating expense | -61.33%12.57K | 0.45%319.22K | -19.68%223.35K | -83.38%44.28K | 94.64%32.5K | 88.60%317.8K | 77.35%278.06K | 533.34%266.5K | 12.95%16.7K | -86.41%168.51K |
Total profit | -51.88%-6.02M | -159.02%-33.1M | -137.29%-14.5M | -112.32%-3.45M | -118.07%-3.97M | -36.20%56.08M | -31.27%38.89M | 49.13%28.01M | 1,042.17%21.95M | -14.85%87.9M |
Less:Income tax cost | -225.80%-907.69K | -159.48%-4.38M | -99.04%45.81K | -80.88%589.08K | -108.13%-278.6K | -31.18%7.37M | -29.96%4.76M | 130.47%3.08M | 383.47%3.43M | -19.36%10.71M |
Net profit | -38.75%-5.12M | -158.95%-28.71M | -142.62%-14.55M | -116.21%-4.04M | -119.91%-3.69M | -36.90%48.71M | -31.44%34.13M | 42.89%24.93M | 1,426.90%18.52M | -14.19%77.19M |
Net profit from continuing operation | -38.75%-5.12M | -158.95%-28.71M | -142.62%-14.55M | -116.21%-4.04M | -119.91%-3.69M | -36.90%48.71M | -31.44%34.13M | 42.89%24.93M | 1,426.90%18.52M | -14.19%77.19M |
Net profit of parent company owners | -38.75%-5.12M | -158.95%-28.71M | -142.62%-14.55M | -116.21%-4.04M | -119.91%-3.69M | -36.90%48.71M | -31.44%34.13M | 42.89%24.93M | 1,426.90%18.52M | -14.19%77.19M |
Earning per share | ||||||||||
Basic earning per share | -50.00%-0.03 | -156.25%-0.18 | -140.91%-0.09 | -117.65%-0.03 | -114.29%-0.02 | -50.00%0.32 | -46.34%0.22 | 21.43%0.17 | 1,300.00%0.14 | -14.67%0.64 |
Diluted earning per share | -50.00%-0.03 | -156.25%-0.18 | -140.91%-0.09 | -117.65%-0.03 | -114.29%-0.02 | -50.00%0.32 | -46.34%0.22 | 21.43%0.17 | 1,300.00%0.14 | -14.67%0.64 |
Other composite income | ||||||||||
Total composite income | -38.75%-5.12M | -158.95%-28.71M | -142.62%-14.55M | -116.21%-4.04M | -119.91%-3.69M | -36.90%48.71M | -31.44%34.13M | 42.89%24.93M | 1,426.90%18.52M | -14.19%77.19M |
Total composite income of parent company owners | -38.75%-5.12M | -158.95%-28.71M | -142.62%-14.55M | -116.21%-4.04M | -119.91%-3.69M | -36.90%48.71M | -31.44%34.13M | 42.89%24.93M | 1,426.90%18.52M | -14.19%77.19M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.